ライフサイエンスコーパス: mitral valve repair

1 st- atrial fibrillation ablation or surgical mitral valve repair).

2 transcatheter valve therapies (for example, mitral valve repair).

3 t alone or coronary artery bypass graft with mitral valve repair.

4 n particular, mechanical cardiac support and mitral valve repair.

5 e as well as the improved outcome related to mitral valve repair.

6 cardiologist can result in increased rate of mitral valve repair.

7 ecting percutaneous treatment strategies for mitral valve repair.

8 of a percutaneous catheter-based system for mitral valve repair.

9 height >/=5 mm) and 5 others (8%) underwent mitral valve repair.

10 roup consisted of 6 patients who had primary mitral valve repair.

11 l annular papillary muscle continuity during mitral valve repair.

12 ler imaging in patients with hemolysis after mitral valve repair.

13 nvolved in the occurrence of hemolysis after mitral valve repair.

14 egurgitation, the most common indication for mitral valve repair.

15 ients with severe MR even after percutaneous mitral valve repair.

16 scharge, 30 days, 6 months, and 1 year after mitral valve repair.

17 uld be considered an alternative to surgical mitral valve repair.

18 oved LV ejection fraction after percutaneous mitral valve repair.

19 chanical energy (pressure-volume area) after mitral valve repair.

20 is relatively normal in patients undergoing mitral valve repair.

21 valve replacement (MVR) may be favored over mitral valve repair.

22 approach should be routinely used in complex mitral valve repairs.

23 % in the CABG-alone group (hazard ratio with mitral-valve repair, 0.90; 95% confidence interval, 0.38

24 52 robotic-assisted clinical operations: 18 mitral valve repairs, 20 cholecystectomies, and 14 Nisse

25 re 28 degrees C) without aortic cross-clamp, mitral valve repair (224/504, 44%) or replacement (280/5

26 luded coronary artery bypass grafting (13%), mitral valve repair (7%), and partial/complete arch repl

27 Survival after mitral valve repair among elderly patients is equivalent

28 undergoing mitral valve surgery, especially mitral valve repair, an approach of earlier identificati

29 able a complete operation that includes both mitral valve repair and ablation of atrial fibrillation.

30 ) and severe mitral regurgitation undergoing mitral valve repair and coronary artery bypass graft ope

31 To review the evolution of mitral valve repair and outline currently favored repair

32 asive aortic (n = 41) and minimally invasive mitral valve repair and replacement (n = 43) between Jul

33 st decade and become the preferred method of mitral valve repair and replacement at certain specializ

34 are fee-for-service beneficiaries undergoing mitral valve repair and replacement over a 10-year perio

35 guiding surgical and percutaneous methods of mitral valve repair and replacement.

36 l per square meter of body-surface area with mitral-valve repair and 60.6+/-39.0 ml per square meter

37 at 12 months between patients who underwent mitral-valve repair and those who underwent mitral-valve

38 al regurgitation (MR) following degenerative mitral valve repair are poorly understood.

39 Flexible annuloplasty devices used in mitral valve repair are, therefore, unlikely to result i

40 Mitral valve repair as a proportion of all mitral valve

41 Mitral valve repair avoids the complications associated

42 rent practice for mitral valve surgery, with mitral valve repair being the technique of choice.

43 g reoperation for mitral regurgitation after mitral valve repair but without hemolysis served as cont

44 to evaluate renal function before and after mitral valve repair by the MitraClip device.

45 Percutaneous edge-to-edge mitral valve repair can be performed safely and a reduct

46 veral groups have now confirmed that complex mitral valve repairs can be carried out robotically with

47 Mitral-valve repair can be accomplished with an investig

48 tients in atrial fibrillation (AF) following mitral valve repair, clinical and echocardiographic foll

49 ral regurgitation to CABG alone or CABG plus mitral-valve repair (combined procedure).

50 In severe MR due to MVP, mitral valve repair compared with MVR provides improved

51 w likelihood of MR recurrence, regardless of mitral valve repair complexity.

52 dge-to-edge technique using the percutaneous mitral valve repair device in an ex vivo pulsatile model

53 commercially treated with this percutaneous mitral valve repair device were analyzed.

54 gurgitation undergoing CABG, the addition of mitral-valve repair did not lead to significant differen

55 Whether mitral valve repair during coronary artery bypass grafti

56 of the mitral valve apparatus from extensive mitral valve repair experience.

57 After mitral valve repair for degenerative mitral regurgitatio

58 gradients can develop in some patients after mitral valve repair for degenerative mitral regurgitatio

59 Mitral valve repair for mitral regurgitation (MR) has be

60 inical results of a percutaneous approach to mitral valve repair for mitral regurgitation (MR).

61 etween 1991 and 2010, patients who underwent mitral valve repair for primary mitral regurgitation wer

62 After mitral valve repair for primary mitral regurgitation, th

63 h a mean (SD) age of 57 (11) years underwent mitral valve repair for regurgitation from posterior lea

64 98.8% complete follow-up) underwent robotic mitral valve repair for severe nonischemic degenerative

65 the commercial experience with transcatheter mitral valve repair for the treatment of mitral regurgit

66 Although mitral valve repair has become recently popularized for

67 Mitral valve repair has become the mainstay of surgical

68 The success of the mitral valve repair has led to increased scrutiny of mit

69 In the current era, mitral valve repair has proven to offer improved short-t

70 Mitral valve repair has reduced LOS and improved in-hosp

71 Percutaneous mitral valve repair improves hemodynamic profiles and in

72 uded coronary artery bypass grafting in 95%, mitral valve repair in 22%, and mitral valve replacement

73 Operations performed included mitral valve repair in 27 patients; mitral valve replace

74 t in 9; coronary artery bypass surgery in 3; mitral valve repair in 2; and septal myectomy, mitral va

75 predict postoperative LVD and outcome after mitral valve repair in patients with primary mitral regu

76 In addition, concomitant mitral valve repair in these patients resulted in a bett

77 bypass grafting (CABG) alone with CABG plus mitral-valve repair in patients with moderate ischemic m

78 Percutaneous mitral valve repair increased end-systolic wall stress (

79 The rates of mitral valve repair increased from 47.7% in the lowest-v

80 We screened 275 patients who had mitral valve repair involving >1 leaflet scallop between

81 In expert centers, mitral valve repair is achieved at low risk and with exc

82 In addition, transcatheter mitral valve repair is also routinely used in high surgi

83 Performance of AVR and concomitant mitral valve repair is associated with a better survival

84 ted that recurrent MR following degenerative mitral valve repair is associated with adverse left vent

85 elderly patients with mitral regurgitation, mitral valve repair is associated with superior early an

86 Mitral valve repair is being explored, with surprisingly

87 gs demonstrate that commercial transcatheter mitral valve repair is being performed in the United Sta

88 Mitral valve repair is currently applied to close to 60%

89 Still, mitral valve repair is far more complex than mitral valv

90 Mitral valve repair is favoured over replacement wheneve

91 Mitral valve repair is superior to replacement.

92 at highest risk for complications, and that mitral valve repair is the treatment of choice for sympt

93 nsecutively operated for MR (procedures: 897 mitral valve repair [MRep] and 447 valve replacement: 23

94 The role of mitral valve repair (MVR) during coronary artery bypass

95 o underwent successful revascularization and mitral valve repair (MVRep) for functional ischemic mitr

96 In the absence of level one evidence, mitral valve repair offers an effective and durable surg

97 ural costs, robotically assisted surgery for mitral valve repair offers the clinical benefit of least

98 Open mitral valve repair (OMVP) is hypothesized to improve sy

99 tients with mitral valve prolapse undergoing mitral valve repair or from organ donors without mitral

100 who required subsequent surgery had elective mitral valve repair or intended replacement.

101 for recurrent rheumatic attacks, the use of mitral valve repair or reconstruction for rheumatic mitr

102 nterval, 0.51-0.62; P<0.0001), and CABG plus mitral valve repair or replacement (adjusted hazard rati

103 D TEE to evaluate mitral regurgitation after mitral valve repair or replacement as a result of mitral

104 =65 years of age undergoing primary isolated mitral valve repair or replacement from 2000 to 2009.

105 In these cases, concomitant mitral valve repair or replacement is usually performed

106 ace subgroups, and among patients undergoing mitral valve repair or replacement, but remained higher

107 proaches include coronary revascularization, mitral valve repair or replacement, cardiomyoplasty, lef

108 ients were withdrawn after randomization for mitral valve repair or replacement.

109 artery bypass grafting (CABG), or CABG plus mitral valve repair or replacement.

110 revascularization in combination with either mitral valve repair or replacement.

111 dy of 612 consecutive patients who underwent mitral valve repair or replacement: 226 patients had rep

112 ry intervention=26%, CABG=33%, and CABG plus mitral valve repair or replacement=5%.

113 hemic mitral regurgitation to undergo either mitral-valve repair or chordal-sparing replacement in or

114 In patients undergoing mitral-valve repair or replacement for severe ischemic m

115 We randomly assigned 251 patients to mitral-valve repair or replacement.

116 ein (OR 1.42, 95% CI 1.21-1.67, p < 0.0001), mitral valve repair (OR 2.86, 95% CI 1.72-4.73, p < 0.00

117 MR include surgical revascularization alone, mitral valve repair, or MVR.

118 Transcatheter mitral valve repair, particularly edge-to-edge leaflet r

119 Thirty-five patients underwent mitral valve repair per current guideline recommendation

120 ty ring or band implantation during surgical mitral valve repair perturbs mitral annular dimensions,

121 effects in patients undergoing percutaneous mitral valve repair (PMVR) using the edge-to-edge techni

122 Mitral-valve repair provided a more durable correction o

123 uence of surgeon case volume on degenerative mitral valve repair rates and outcomes.

124 nnual mitral volumes of >50 and degenerative mitral valve repair rates of >70%, compared with surgeon

125 Degenerative mitral valve repair rates remain highly variable, despit

126 The minimally invasive approach for complex mitral valve repair requires continued development and i

127 If untreated at the time of surgical mitral valve repair, significant residual TR negatively

128 Surgical mitral valve repair (SMVR) remains the gold standard for

129 In the hands of reference mitral valve-repair surgeons, 95-100% of degenerative va

130 ly expand the range of patients suitable for mitral valve repair surgery and give further evidence to

131 e interstitial cells (MVICs) obtained during mitral valve repair surgery of a proband.

132 itral regurgitation (MR) were treated with a mitral valve repair system (MVRS) via small left thoraco

133 (Pivotal Study of a Percutaneous Mitral Valve Repair System [EVEREST II]; NCT00209274).

134 Increasing use of mitral valve repair techniques resulted in a marked decr

135 The increased use of mitral valve repair techniques to address mitral valve d

136 The use of transcatheter mitral valve repair (TMVR) has gained widespread accepta

137 However, the results with transcatheter mitral valve repair (TMVR) in prohibitive-risk DMR patie

138 Transcatheter mitral valve repair (TMVR) is a treatment option in pati

139 e devices currently available, transcatheter mitral valve repair (TMVr) remains challenging in comple

140 these observational data suggest that adding mitral valve repair to CABG in patients with left ventri

141 Robotic technology now allows complex mitral valve repairs to be carried out via small incisio

142 chemic mitral regurgitation, the addition of mitral-valve repair to CABG did not result in a higher d

143 a clinically meaningful advantage of adding mitral-valve repair to CABG.

144 derate regurgitation, the benefits of adding mitral-valve repair to coronary-artery bypass grafting (

145 me in which patients underwent transcatheter mitral valve repair using the Edwards PASCAL TMVr system

146 rea (MVA) is important to guide percutaneous mitral valve repair using the MitraClip system.

147 tery bypass graft, aortic valve replacement, mitral valve repair) using an interrupted time series mo

148 ted in pregnancy than valvular stenosis, but mitral valve repair, usually feasible for nonrheumatic p

149 e risk adjustment was modified to adjust for mitral valve repair versus replacement.

150 ), and the proportion of patients undergoing mitral valve repair (versus replacement) increased (24.7

151 cic Surgeons predicted risk of mortality for mitral valve repair was 4.8% (2.1-9.0) and 6.8% (2.9-10.

152 The addition of mitral-valve repair was associated with a longer bypass

153 Concomitant mitral-valve repair was associated with a reduced preval

154 Mitral-valve repair was associated with a reduced preval

155 ents commercially treated with transcatheter mitral valve repair were analyzed.

156 Effect of AVR and concomitant mitral valve repair were investigated.

157 ecutive patients with hemolytic anemia after mitral valve repair who were referred for mitral reopera

158 Transcatheter mitral valve repair with a MitraClip device is also prod

159 Mitral valve repair with annuloplasty has become a widel

160 Mitral valve repair with annuloplasty has become a widel

161 l regurgitation (MR) has been reported after mitral valve repair with annuloplasty in patients with d

162 Percutaneous mitral valve repair with the MitraClip device has emerge

163 ry determination who underwent transcatheter mitral valve repair with the MitraClip device in multice

164 In a randomized trial comparing mitral-valve repair with mitral-valve replacement in pat

165 y that enables a double-orifice edge-to-edge mitral valve repair without cardiopulmonary bypass in an